Elucidating the exact pharmacological system of action (MOA) of The natural way developing compounds is often hard. Whilst Tarselli et al. (60) designed the initial de novo artificial pathway to conolidine and showcased that this naturally transpiring compound successfully suppresses responses to the two chemically induced and inflammation-derived